C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 1 filers reported holding C4 THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $22,801 | -11.6% | 12,259 | +30.7% | 0.00% | 0.0% |
Q2 2023 | $25,801 | +214908.3% | 9,382 | +144.6% | 0.00% | – |
Q1 2023 | $12 | +33.3% | 3,836 | +156.2% | 0.00% | – |
Q4 2022 | $9 | -100.0% | 1,497 | -85.2% | 0.00% | -100.0% |
Q3 2022 | $89,000 | +323.8% | 10,100 | +256.6% | 0.00% | – |
Q2 2022 | $21,000 | -92.2% | 2,832 | -74.3% | 0.00% | -100.0% |
Q1 2022 | $268,000 | +72.9% | 11,036 | +128.6% | 0.00% | 0.0% |
Q4 2021 | $155,000 | +23.0% | 4,827 | +70.9% | 0.00% | 0.0% |
Q3 2021 | $126,000 | +186.4% | 2,824 | +146.9% | 0.00% | +200.0% |
Q2 2021 | $44,000 | -42.1% | 1,144 | -44.9% | 0.00% | 0.0% |
Q1 2021 | $76,000 | +744.4% | 2,076 | +625.9% | 0.00% | – |
Q4 2020 | $9,000 | – | 286 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 481,094 | $21,495,000 | 5.67% |
Soleus Capital Management, L.P. | 750,633 | $33,538,000 | 5.23% |
Bain Capital Life Sciences Investors, LLC | 1,642,209 | $73,374,000 | 4.55% |
RTW INVESTMENTS, LP | 2,494,965 | $111,475,000 | 1.68% |
P.A.W. CAPITAL CORP | 40,000 | $1,787,000 | 1.59% |
Perceptive Advisors | 2,258,566 | $100,913,000 | 1.47% |
SPHERA FUNDS MANAGEMENT LTD. | 381,774 | $17,058,000 | 1.43% |
CLOUGH CAPITAL PARTNERS L P | 347,500 | $15,526,000 | 0.94% |
HighVista Strategies LLC | 29,341 | $1,311,000 | 0.87% |
RA Capital Management | 1,377,569 | $61,550,000 | 0.85% |